L 783281Alternative Names: Demethylasterriquinone B1
Latest Information Update: 30 Mar 2010
At a glance
- Originator Merck & Co
- Developer Duke University; Merck & Co
- Class Antihyperglycaemics; Indoles
- Mechanism of Action Protein tyrosine kinase stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Neurological disorders; Type 1 diabetes mellitus; Type 2 diabetes mellitus